Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Irritable Bowel Syndrome With Constipation (IBS-C)”

52 trials

Showing 20 of 52 results

Testing effectiveness (Phase 2)Study completedNCT01722318
What this trial is testing

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Who this might be right for
Irritable Bowel Syndrome Characterized by Constipation
Bausch Health Americas, Inc. 428
Testing effectiveness (Phase 2)Study completedNCT00215566
What this trial is testing

Evaluate the Safety, Tolerability and Pharmacodynamics of DDP733 for IBS-c

Who this might be right for
Irritable Bowel Syndrome With ConstipationIrritable Bowel Syndrome
Dynogen Pharmaceuticals 90
Not applicableStudy completedNCT01162863
What this trial is testing

Effects of Lubiprostone on Gastrointestinal Transit & pH in Irritable Bowel Syndrome (IBS) With Constipation

Who this might be right for
Irritable Bowel SyndromeConstipation
University of Michigan 60
Testing effectiveness (Phase 2)Ended earlyNCT04043455
What this trial is testing

Olorinab in Irritable Bowel Syndrome With Predominant Constipation (IBS-C) and Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D)

Who this might be right for
Irritable Bowel Syndrome
Arena Pharmaceuticals 273
Large-scale testing (Phase 3)Study completedNCT02706483
What this trial is testing

Long Term Safety Study of Plecanatide

Who this might be right for
Irritable Bowel Syndrome
Bausch Health Americas, Inc. 2,272
Not applicableUnknownNCT05240521
What this trial is testing

Efficacy and Safety, Tolerability of GA-AT0119 in IBS-C

Who this might be right for
Irritable Bowel Syndrome With Constipation (IBS-C)
Devintec Sagl 60
Large-scale testing (Phase 3)Active Not RecruitingNCT05643534
What this trial is testing

Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years

Who this might be right for
Irritable Bowel Syndrome With Constipation (IBS-C)
Ardelyx 180
Testing effectiveness (Phase 2)Study completedNCT00460811
What this trial is testing

Randomized, Double-blind, Dose-range-finding, Phase 2 Study of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

Who this might be right for
Irritable Bowel Syndrome With Constipation
Ironwood Pharmaceuticals, Inc. 420
Large-scale testing (Phase 3)UnknownNCT00547469
What this trial is testing

The Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Who this might be right for
Irritable Bowel Syndrome
Dynogen Pharmaceuticals 360
Testing effectiveness (Phase 2)Active Not RecruitingNCT06553547
What this trial is testing

4-Week, Multi-center Dose-Ranging Study for the IBS-C in Pts. 6 to <12 Yrs

Who this might be right for
Irritable Bowel Syndrome With Constipation (IBS-C)
Ardelyx 72
Large-scale testing (Phase 3)Study completedNCT04026113
What this trial is testing

Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC)

Who this might be right for
Functional ConstipationIrritable Bowel Syndrome With Constipation
AbbVie 438
Large-scale testing (Phase 3)Enrolling By InvitationNCT05905926
What this trial is testing

Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-C

Who this might be right for
Irritable Bowel Syndrome With Constipation (IBS-C)
Ardelyx 150
Testing effectiveness (Phase 2)Study completedNCT01056107
What this trial is testing

Effects of ROSE-010 on GI Transit in Constipation Predominant Irritable Bowel Syndrome (C-IBS) Patients

Who this might be right for
Irritable Bowel Syndrome Constipation Predominant
Mayo Clinic 52
Testing effectiveness (Phase 2)Looking for participantsNCT07545772
What this trial is testing

Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)

Who this might be right for
Irritable Bowel SyndromeConstipation
Eli Lilly and Company 342
Testing effectiveness (Phase 2)Study completedNCT02082457
What this trial is testing

Efficacy and Safety of YKP10811 in Subjects With Irritable Bowel Syndrome With Constipation

Who this might be right for
Irritable Bowel SyndromeConstipation
SK Chemicals Co., Ltd. 273
Testing effectiveness (Phase 2)Study completedNCT02495623
What this trial is testing

The Effect of SYN-010 on Subjects With IBS-C

Who this might be right for
Irritable Bowel Syndrome With Constipation (IBS-C)
Theriva Biologics, Inc. 63
Large-scale testing (Phase 3)Study completedNCT00796354
What this trial is testing

Constipation Associated With Irritable Bowel Syndrome (IBS-C)

Who this might be right for
Constipation
Norgine 210
Not applicableStudy completedNCT03150212
What this trial is testing

Effect of Saccharomyces Cerevisiae on the Improvement of Gastro-intestinal Disorders Associated to IBS With C Phenotype

Who this might be right for
Constipation-predominant Irritable Bowel Syndrome
Lesaffre International 456
Large-scale testing (Phase 3)Study completedNCT02387359
What this trial is testing

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Who this might be right for
Irritable Bowel Syndrome Characterized by Constipation
Bausch Health Americas, Inc. 1,054
Large-scale testing (Phase 3)Study completedNCT01880424
What this trial is testing

A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

Who this might be right for
Irritable Bowel Syndrome With Constipation (IBS-C)
AstraZeneca 1,722
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation